Patients Must Have Progressive Disease after 1st Line of Therapy to Enroll in ONC201 Trial - 102191

Spotlight
Video

Patients Must Have Progressive Disease after 1st Line of Therapy to Enroll in ONC201 Trial

Cancer-News has 111 videos Subscribe Here

Loading........
Description: Andrew Chi, MD, PhD at NYU Langone Medical Center Explains How Patients Must Have Progressive Disease after 1st Line of Therapy to Enroll in ONC201 Trial. Clinical Trial: ONC201 in Adults With Recurrent H3 K27M High-grade Glioma.
Shared By : Cancer-News
Posted on : 03/20/18
Added : 5 months ago
Category : Brain Cancer



Recommended

Nothing found.